Entry Detail



General Information

Database ID:exR0000383
RNA Name:AGPAT4
RNA Type:mRNA
Chromosome:chr6
Starnd:-
Coordinate:
Start Site(bp):161129967End Site(bp):161274061
External Links:ENSG00000026652



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CLIC1
chr6
31730581
31739763
-
TMEM237
chr2
201620184
201643570
-
EIF4G2
chr11
10797050
10808940
-
METAP1
chr4
98995659
99062809
+
TNFRSF13B
chr17
16929816
16972118
-
ILF2
chr1
153661788
153671028
-
SPAG16
chr2
213284379
214410501
+
FASN
chr17
82078338
82098294
-
DCK
chr4
70992538
71030914
+
RPL13
chr16
89560657
89566828
+
HEXIM1
chr17
45148502
45152101
+
DDB1
chr11
61299451
61342596
-
PRR14
chr16
30650717
30656440
+
RPS27A
chr2
55231903
55235853
+
SYMPK
chr19
45815410
45863194
-
SNRPD2
chr19
45687454
45692569
-
RALY
chr20
33993646
34108308
+
BSG
chr19
571277
583493
+
RFT1
chr3
53088483
53130453
-
LRRN1
chr3
3799431
3849834
+
HP1BP3
chr1
20740266
20787323
-
RTF1
chr15
41408408
41483563
+
PHLDA1
chr12
76025447
76033932
-
CLIP1
chr12
122271432
122422632
-
GART
chr21
33503931
33543491
-
TOMM22
chr22
38681957
38685421
+
CCDC102A
chr16
57512181
57536571
-
TXLNA
chr1
32179675
32198285
+
TMED9
chr5
177592203
177597242
+
YIF1B
chr19
38303558
38317273
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005394.2
chr19
28435388
28727680
-
AL353719.1
chr10
99621055
99621918
+
JAKMIP2-AS1
chr5
147559994
147662009
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.